NCT06388109 Positive Peers Intervention Clinical Trial
| NCT ID | NCT06388109 |
| Status | Recruiting |
| Phase | — |
| Sponsor | MetroHealth Medical Center |
| Condition | HIV Infections |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2024-06-03 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 250 participants in total. It began in 2024-06-03 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if the Positive Peers mobile app intervention increases rates of viral suppression in young (13-34 y/o) persons with HIV. Does use of the Positive Peers app improve viral suppression among young minority persons with HIV? What user characteristics are associated with a) viral suppression, b) retention in care, and c) perceived HIV-related stigma? Participants will: * download the mobile app onto their personal smartphone * Use the mobile app as they find useful * complete online surveys at enrollment, 3 mo, 6, mo, 9 mo and 12 months.
Eligibility Criteria
Inclusion Criteria: * HIV+ * Identifies as either a racial, ethnic, sexual or gender minority One of the following: * Newly diagnosed within last 12 months * Out of care (greater than 6 months between any two HIV provider visits in last 24 months) * Not virally suppressed (any viral load \> 200 copies in last 24 months) * Has a working smartphone * Functional English ability Exclusion Criteria: * prior use of Positive Peers mobile app
Contact & Investigator
Ann Avery, MD
PRINCIPAL INVESTIGATOR
MetroHealth/ CWRU
Frequently Asked Questions
Who can join the NCT06388109 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 34 Years, studying HIV Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06388109 currently recruiting?
Yes, NCT06388109 is actively recruiting participants. Contact the research team at jmsmith@metrohealth.org for enrollment information.
Where is the NCT06388109 trial being conducted?
This trial is being conducted at Van Nuys, United States, Newark, United States, Cincinnati, United States, Columbus, United States and 2 additional locations.
Who is sponsoring the NCT06388109 clinical trial?
NCT06388109 is sponsored by MetroHealth Medical Center. The principal investigator is Ann Avery, MD at MetroHealth/ CWRU. The trial plans to enroll 250 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.